X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (37670) 37670
Newsletter (3576) 3576
Newspaper Article (265) 265
Magazine Article (173) 173
Book Chapter (158) 158
Dissertation (99) 99
Publication (43) 43
Conference Proceeding (42) 42
Book / eBook (35) 35
Web Resource (24) 24
Reference (11) 11
Book Review (7) 7
Transcript (5) 5
Government Document (3) 3
Journal / eJournal (2) 2
Paper (2) 2
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24257) 24257
male (15722) 15722
female (12546) 12546
diabetic nephropathies (11387) 11387
diabetic nephropathy (11113) 11113
middle aged (10066) 10066
animals (8621) 8621
adult (8335) 8335
diabetes (8114) 8114
urology & nephrology (6785) 6785
aged (6317) 6317
endocrinology & metabolism (5284) 5284
nephropathy (5085) 5085
diabetic nephropathies - physiopathology (4697) 4697
risk factors (4515) 4515
diabetic-nephropathy (4512) 4512
research (4503) 4503
rats (4321) 4321
diabetes mellitus (3875) 3875
diabetic nephropathies - metabolism (3712) 3712
diabetic nephropathies - pathology (3679) 3679
diabetes mellitus, type 2 - complications (3464) 3464
hypertension (3411) 3411
diabetic nephropathies - drug therapy (3374) 3374
diabetic nephropathies - etiology (3286) 3286
mice (3226) 3226
kidney diseases (3124) 3124
oxidative stress (3120) 3120
type 2 diabetes (3026) 3026
diabetic nephropathies - complications (2967) 2967
albuminuria (2805) 2805
mellitus (2737) 2737
proteinuria (2710) 2710
diabetic nephropathies - therapy (2674) 2674
glomerular filtration rate (2660) 2660
diabetic nephropathies - blood (2657) 2657
expression (2656) 2656
disease (2567) 2567
microalbuminuria (2482) 2482
diabetic nephropathies - prevention & control (2468) 2468
analysis (2349) 2349
diabetic nephropathies - epidemiology (2330) 2330
diabetic nephropathies - diagnosis (2298) 2298
kidney - pathology (2287) 2287
disease progression (2280) 2280
glucose (2255) 2255
blood pressure (2249) 2249
medicine, general & internal (2248) 2248
diabetes mellitus, type 1 - complications (2221) 2221
diabetic nephropathies - genetics (2184) 2184
adolescent (2153) 2153
kidney (2149) 2149
progression (2122) 2122
care and treatment (2117) 2117
nephrology (2116) 2116
development and progression (2055) 2055
mortality (2052) 2052
kidneys (2026) 2026
transplantation (2010) 2010
time factors (1968) 1968
inflammation (1963) 1963
chronic kidney failure (1959) 1959
prevalence (1882) 1882
medical research (1832) 1832
health aspects (1831) 1831
risk (1824) 1824
complications (1822) 1822
medicine, research & experimental (1770) 1770
kidney - metabolism (1757) 1757
pharmacology & pharmacy (1732) 1732
diabetics (1669) 1669
fibrosis (1635) 1635
medicine, experimental (1635) 1635
blood-pressure (1607) 1607
blood glucose - metabolism (1601) 1601
proteins (1535) 1535
follow-up studies (1531) 1531
biochemistry & molecular biology (1521) 1521
diabetic nephropathies - urine (1521) 1521
treatment outcome (1521) 1521
kidney - physiopathology (1494) 1494
physiological aspects (1490) 1490
medicine & public health (1478) 1478
kidney - drug effects (1469) 1469
kidney transplantation (1468) 1468
chronic kidney disease (1463) 1463
diabetes mellitus, type 2 - physiopathology (1456) 1456
kidney failure, chronic - therapy (1451) 1451
type 1 diabetes (1414) 1414
angiotensin-converting enzyme inhibitors - therapeutic use (1402) 1402
creatinine - blood (1375) 1375
diabetes mellitus, type 1 - physiopathology (1371) 1371
chronic kidney-disease (1361) 1361
diabetic nephropathies - surgery (1360) 1360
prognosis (1357) 1357
diabetes mellitus, type 2 - blood (1356) 1356
rats, sprague-dawley (1327) 1327
apoptosis (1319) 1319
rodents (1318) 1318
hyperglycemia (1309) 1309
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (38830) 38830
Japanese (963) 963
German (544) 544
Chinese (438) 438
French (366) 366
Russian (354) 354
Spanish (343) 343
Polish (226) 226
Korean (180) 180
Czech (126) 126
Italian (107) 107
Portuguese (83) 83
Hungarian (62) 62
Bulgarian (31) 31
Slovak (30) 30
Croatian (24) 24
Finnish (23) 23
Serbian (22) 22
Danish (21) 21
Hebrew (18) 18
Persian (16) 16
Dutch (15) 15
Swedish (13) 13
Turkish (13) 13
Romanian (10) 10
Ukrainian (10) 10
Bosnian (6) 6
Norwegian (4) 4
Arabic (2) 2
Greek (2) 2
Indonesian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 9, pp. 839 - 848
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2015, Volume 314, Issue 9, pp. 884 - 894
IMPORTANCE: Steroidal mineralocorticoid receptor antagonists, when added to a renin-angiotensin system blocker, further reduce proteinuria in patients with... 
Blood Pressure | Creatinine | Glomerular Filtration Rate | Diabetic Nephropathies | Double-Blind Method | Drug Administration Schedule | Naphthyridines | Administration, Oral | Angiotensin Receptor Antagonists | Humans | Middle Aged | Male | Albuminuria | Incidence | Dose-Response Relationship, Drug | Hyperkalemia | Analysis of Variance | Angiotensin-Converting Enzyme Inhibitors | Least-Squares Analysis | Female | Aged | Diabetes Mellitus, Type 2 | Mineralocorticoid Receptor Antagonists | Potassium | KIDNEY-DISEASE | MEDICINE, GENERAL & INTERNAL | ANTAGONIST | INHIBITION | MORBIDITY | SPIRONOLACTONE | BAY 94-8862 | PROTEINURIA | BLOCKADE | BLOOD-PRESSURE | MINERALOCORTICOID RECEPTOR | Naphthyridines - adverse effects | Diabetic Nephropathies - drug therapy | Diabetes Mellitus, Type 2 - ethnology | Glomerular Filtration Rate - drug effects | Diabetic Nephropathies - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hyperkalemia - epidemiology | Blood Pressure - drug effects | Diabetes Mellitus, Type 2 - complications | Diabetic Nephropathies - urine | Diabetes Mellitus, Type 2 - urine | Diabetic Nephropathies - ethnology | Creatinine - urine | Mineralocorticoid Receptor Antagonists - therapeutic use | Albuminuria - drug therapy | Hyperkalemia - chemically induced | Potassium - blood | Angiotensin Receptor Antagonists - therapeutic use | Naphthyridines - administration & dosage | Proteins | Clinical trials | Side effects | Diabetes | Antagonist drugs | ACE inhibitors
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 1440-1681, 10/2006, Volume 33, Issue 10, pp. 940 - 945
SUMMARY • Chronic hyperglycaemia in diabetes leads to the overproduction of free radicals and evidence is increasing that these contribute to the development... 
lipid peroxidation | diabetic nephropathy | oxidative stress | curcumin | Lipid peroxidation | Oxidative stress | Diabetic nephropathy | Curcumin | PATHOGENESIS | PHYSIOLOGY | PHARMACOLOGY & PHARMACY | Diabetes Mellitus, Experimental - drug therapy | Glutathione - metabolism | Plant Extracts - pharmacology | Body Weight - drug effects | Diabetic Nephropathies - drug therapy | Diabetic Nephropathies - blood | Diabetes Mellitus, Experimental - mortality | Diabetes Mellitus, Experimental - blood | Blood Pressure - drug effects | Drug Evaluation, Preclinical | Superoxide Dismutase - metabolism | Malondialdehyde - metabolism | Kidney - drug effects | Curcumin - pharmacology | Rats | Survival Rate | Kidney - anatomy & histology | Kidney - cytology | Rats, Sprague-Dawley | Diabetic Nephropathies - mortality | Blood Glucose - drug effects | Catalase - metabolism | Animals | Curcuma | Oxidative Stress - drug effects | Kidney, drug effects | Kidney, anatomy and histology | Oxidative Stress, drug effects | Superoxide Dismutase, metabolism | Blood Glucose, drug effects | Diabetes Mellitus, Experimental, mortality | Curcumin, pharmacology | Diabetic Nephropathies, blood | Glutathione, metabolism | Blood Pressure, drug effects | Plant Extracts, pharmacology | Catalase, metabolism | Diabetes Mellitus, Experimental, drug therapy | Diabetes Mellitus, Experimental, blood | Diabetic Nephropathies, drug therapy | Malondialdehyde, metabolism | Diabetic Nephropathies, mortality | Body Weight, drug effects | Kidney, cytology | Diabetic nephropathies
Journal Article
American journal of physiology. Regulatory, integrative and comparative physiology, ISSN 0363-6119, 2013, Volume 304, Issue 2, pp. R110 - R120
We and other investigators have reported that bilirubin and its precursor biliverdin may have beneficial effects on diabetic vascular complications, including... 
Phycobilin | Albuminuria | Bilirubin | Nad(P)h oxidase | Superoxide production | superoxide production | ACTIVATION | PHYSIOLOGY | C-PHYCOCYANIN | RATS | NAD(P)H oxidase | albuminuria | VASCULAR COMPLICATIONS | HEART-DISEASE | bilirubin | phycobilin | KIDNEY | EXPRESSION | CORONARY-ARTERY-DISEASE | SERUM BILIRUBIN | Kidney - pathology | Diabetic Nephropathies - etiology | Phycobilins - administration & dosage | Humans | NADPH Oxidases - metabolism | Male | Diabetes Mellitus, Type 2 - metabolism | Bilirubin - pharmacology | Biliverdine - pharmacology | Kidney - metabolism | Diabetic Nephropathies - physiopathology | Time Factors | Phycobilins - pharmacology | Superoxides - metabolism | Albuminuria - metabolism | Phycocyanin - pharmacology | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Kidney - physiopathology | Disease Models, Animal | Phycocyanin - administration & dosage | Phycobilins - isolation & purification | Diabetic Nephropathies - pathology | Kidney - drug effects | Albuminuria - etiology | Administration, Oral | Spirulina - chemistry | Diabetic Nephropathies - metabolism | Mice, Inbred C57BL | Cells, Cultured | Gene Expression Regulation | Diabetic Nephropathies - genetics | Antioxidants - pharmacology | Phycocyanin - isolation & purification | Albuminuria - prevention & control | Fibronectins - metabolism | Animals | Antioxidants - isolation & purification | Antioxidants - administration & dosage | Mice | Oxidative Stress - drug effects | Diabetes Mellitus, Type 2 - drug therapy | Transforming Growth Factor beta - metabolism | Prevention | Oxidative stress | Spirulina | Phytochemistry | Diabetic nephropathies | Physiological aspects | Research | Health aspects
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2014, Volume 64, Issue 4, pp. 510 - 533
The incidence and prevalence of diabetes mellitus have grown significantly throughout the world, due primarily to the increase in type 2 diabetes. This overall... 
Nephrology | cardiovascular disease | medical home | nutrition | end-stage renal disease (ESRD) | glycemia | diabetes mellitus | diabetic kidney disease (DKD) | chronic kidney disease (CKD) | hypertension | LONG-TERM | GLYCEMIC CONTROL | SEVERE HYPOGLYCEMIA | REVERSE EPIDEMIOLOGY | BLOOD-PRESSURE | GLOMERULAR-FILTRATION-RATE | DIETARY-PROTEIN RESTRICTION | CLINICAL-PRACTICE GUIDELINE | UROLOGY & NEPHROLOGY | HEMOGLOBIN A(1C) LEVELS | STAGE RENAL-DISEASE | Prevalence | Humans | Middle Aged | Cardiovascular Diseases - therapy | Diabetic Nephropathies - blood | Renal Insufficiency, Chronic - complications | Diabetic Nephropathies - diagnosis | Diabetic Nephropathies - therapy | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Kidney Function Tests | Renal Insufficiency, Chronic - epidemiology | Renal Insufficiency, Chronic - therapy | Cardiovascular Diseases - complications | Diabetes Mellitus, Type 2 - therapy | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Renal Insufficiency, Chronic - diagnosis | Child | Diabetes Mellitus, Type 2 - complications | Blood Glucose - analysis | Antihypertensive Agents - therapeutic use | Diabetes Mellitus, Type 2 - blood | Adolescent | Aged | Diabetic Nephropathies - epidemiology | Blood Glucose - metabolism | Type 2 diabetes | African Americans | Complications and side effects | Health aspects | Risk factors | Diabetic nephropathies
Journal Article
American Journal of Physiology: Cell Physiology, ISSN 1522-1563, 2017, Volume 313, Issue 4, pp. C430 - C447
Aberrant expression of microRNAs (miRs) contributes to diabetic renal complications, including renal hypertrophy and matrix protein accumulation. Reduced... 
Cell hypertrophy and fibrosis | Diabetic nephropathy | MicroRNA | MTOR complex 1 | MAMMALIAN TARGET | PHYSIOLOGY | ACTIVATED PROTEIN-KINASE | mTOR complex 1 | RAPAMYCIN COMPLEXES | INDUCED COLLAGEN EXPRESSION | DOWN-REGULATION | DIABETIC-NEPHROPATHY | DNA-SYNTHESIS | CELL BIOLOGY | GROWTH-FACTOR-BETA | GENE-EXPRESSION | microRNA | AKT KINASE | diabetic nephropathy | cell hypertrophy and fibrosis | Diabetic Nephropathies - enzymology | Phosphorylation | Cell Proliferation | TOR Serine-Threonine Kinases - metabolism | MicroRNAs - metabolism | Diabetic Nephropathies - blood | Mechanistic Target of Rapamycin Complex 1 | Multiprotein Complexes - metabolism | Transfection | RNA Interference | Glomerular Mesangium - metabolism | Kidney Tubules, Proximal - enzymology | 3' Untranslated Regions | Proto-Oncogene Proteins c-akt - metabolism | Disease Models, Animal | Diabetes Mellitus, Type 1 - enzymology | Kidney Glomerulus - enzymology | PTEN Phosphohydrolase - genetics | Diabetic Nephropathies - pathology | Kidney Tubules, Proximal - pathology | Signal Transduction | Cells, Cultured | Diabetes Mellitus, Type 1 - pathology | Diabetes Mellitus, Type 1 - genetics | PTEN Phosphohydrolase - metabolism | Rats | Diabetic Nephropathies - genetics | Epithelial Cells - pathology | Kidney Glomerulus - pathology | Fibronectins - metabolism | Gene Expression Regulation, Enzymologic | Glomerular Mesangium - pathology | Animals | Diabetes Mellitus, Type 1 - blood | Epithelial Cells - enzymology | Mice | MicroRNAs - genetics | Blood Glucose - metabolism | Transforming Growth Factor beta - metabolism | Hypertrophy | Physiological aspects | Epithelial cells | Fibrosis | Diabetic nephropathies
Journal Article
Journal Article